Tag: (AUTL)

Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. This year’s metric has recorded a Price decrease of -34.63%. However, over the past six months, we’ve seen a weaker performance of 66.40%. The price of AUTL leaped by -33.49% over the last 30 days. And in the last five days, it has fallen by -13.02%. Autolus Therapeutics plc ADR had a pretty favorable run when it comes to the market performance. Over the past year, the company’s stock reached a high of

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Autolus Therapeutics plc ADR’s current trading price is -16.11% away from its 52-week high, while its distance from the 52-week low is 288.20%. The stock’s price range during this period has varied between $1.61 and $7.45. The company, active in the Healthcare sector, saw a trading volume of around 0.6 million for the day, considerably lower average daily volume of 1.75 million observed over the last three months. The stock market performance of Autolus Therapeutics

A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. Year to date metric has recorded a loss of -16.30%.However, over the last six months, we can see a weaker performance of 76.72%. Over the last 30 days, the price of AUTL has leaped by -15.91%. And in the last five days, it has fallen by -10.17%. Autolus Therapeutics plc ADR’s stock has had a calm market performance. The 1-year high for the company’s stock was $7.45 on 01/12/24, and the lowest